193 related articles for article (PubMed ID: 1471539)
1. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging.
Fujimoto T; Nakano T; Takano T; Hokazono Y; Asakura T; Tsuji T
Acta Psychiatr Scand; 1992 Dec; 86(6):455-62. PubMed ID: 1471539
[TBL] [Abstract][Full Text] [Related]
2. Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies.
Keshavan MS; Sanders RD; Pettegrew JW; Dombrowsky SM; Panchalingam KS
Schizophr Res; 1993 Oct; 10(3):241-6. PubMed ID: 8260442
[TBL] [Abstract][Full Text] [Related]
3. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.
Pettegrew JW; Keshavan MS; Minshew NJ
Schizophr Bull; 1993; 19(1):35-53. PubMed ID: 8451612
[TBL] [Abstract][Full Text] [Related]
4. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia.
Kato T; Shioiri T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
Psychiatry Res; 1995 Sep; 61(3):151-60. PubMed ID: 8545499
[TBL] [Abstract][Full Text] [Related]
5. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia.
Calabrese G; Deicken RF; Fein G; Merrin EL; Schoenfeld F; Weiner MW
Biol Psychiatry; 1992 Jul; 32(1):26-32. PubMed ID: 1391294
[TBL] [Abstract][Full Text] [Related]
6. 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia.
Deicken RF; Calabrese G; Merrin EL; Meyerhoff DJ; Dillon WP; Weiner MW; Fein G
Biol Psychiatry; 1994 Oct; 36(8):503-10. PubMed ID: 7827212
[TBL] [Abstract][Full Text] [Related]
7. Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study.
Deicken RF; Calabrese G; Merrin EL; Vinogradov S; Fein G; Weiner MW
Biol Psychiatry; 1995 Sep; 38(5):279-86. PubMed ID: 7495921
[TBL] [Abstract][Full Text] [Related]
8. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism.
Yacubian J; de Castro CC; Ometto M; Barbosa E; de Camargo CP; Tavares H; Cerri GG; Gattaz WF
Schizophr Res; 2002 Dec; 58(2-3):117-22. PubMed ID: 12409151
[TBL] [Abstract][Full Text] [Related]
9. MRI in schizophrenia: basal ganglia and white matter T1 times.
Harvey I; Ron MA; Murray R; Lewis S; Barker G; McManus D
Psychol Med; 1991 Aug; 21(3):587-98. PubMed ID: 1946848
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.
Hinsberger AD; Williamson PC; Carr TJ; Stanley JA; Drost DJ; Densmore M; MacFabe GC; Montemurro DG
J Psychiatry Neurosci; 1997 Mar; 22(2):111-7. PubMed ID: 9074305
[TBL] [Abstract][Full Text] [Related]
11. Schizophrenia and the corpus callosum: developmental, structural and functional relationships.
David AS
Behav Brain Res; 1994 Oct; 64(1-2):203-11. PubMed ID: 7840887
[TBL] [Abstract][Full Text] [Related]
12. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study.
Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Morrison-Stewart S; Thompson RT
Schizophr Res; 1994 Oct; 13(3):209-15. PubMed ID: 7841133
[TBL] [Abstract][Full Text] [Related]
13. Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study.
Heckers S; Heinsen H; Heinsen Y; Beckmann H
Biol Psychiatry; 1991 Mar; 29(6):556-66. PubMed ID: 2054430
[TBL] [Abstract][Full Text] [Related]
14. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms.
Fukuzako H; Fukuzako T; Takeuchi K; Ohbo Y; Ueyama K; Takigawa M; Fujimoto T
Prog Neuropsychopharmacol Biol Psychiatry; 1996 May; 20(4):629-40. PubMed ID: 8843487
[TBL] [Abstract][Full Text] [Related]
15. Basal ganglia phosphorous metabolism in chronic schizophrenia.
Deicken RF; Calabrese G; Merrin EL; Fein G; Weiner MW
Am J Psychiatry; 1995 Jan; 152(1):126-9. PubMed ID: 7802103
[TBL] [Abstract][Full Text] [Related]
16. Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy.
Griffey RH; Brown MS; Bankhurst AD; Sibbitt RR; Sibbitt WL
Arthritis Rheum; 1990 Jun; 33(6):827-33. PubMed ID: 2363738
[TBL] [Abstract][Full Text] [Related]
17. Planum temporale asymmetry and thought disorder in schizophrenia.
Rossi A; Serio A; Stratta P; Petruzzi C; Schiazza G; Mancini F; Casacchia M
Schizophr Res; 1994 Apr; 12(1):1-7. PubMed ID: 8018581
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.
Fujimoto T; Nakano T; Takano T; Takeuchi K; Yamada K; Fukuzako T; Akimoto H
Biol Psychiatry; 1996 Jul; 40(1):14-8. PubMed ID: 8780850
[TBL] [Abstract][Full Text] [Related]
19. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy.
Fukuzako H
World J Biol Psychiatry; 2001 Apr; 2(2):70-82. PubMed ID: 12587188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
